Hongbin Yi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 2

Top Topics

Chemotherapy Induced

Epidermal Growth Factor Receptor

Ejection Fraction

Small Cell Lung Cancer

Top Venues

International journal of clinical pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Yingdan Cao, Hongbin Yi, Fenghao Shi, XiaoXia Wei, Sheng Han
Cost-effectiveness analysis of amivantamab plus chemotherapy for non-small cell lung cancer patients with epidermal growth factor receptor exon 20 insertions in the United States. International journal of clinical pharmacy (2024)
Hongbin Yi, Fenghao Shi, Zihao Wang, Liping Kuai, Dongyan Xu, Yu Xie, Hua Xing
Impacts of adjustment of National Reimbursement Drug List on orphan drugs volume and spending in China: an interrupted time series analysis. BMJ open 13 (10) (2023)